When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - Lilly launches late-stage study of baricitinib in COVID-19
Eli Lilly and Company
Enrollment is underway in a Phase 3 clinical trial, COV-BARRIER, evaluating Eli Lilly's (NYSE:LLY) Olumiant (baricitinib), an oral JAK1/JAK2 inhibitor licensed from Incyte (NASDAQ:INCY), in hospitalized COVID-19 patients including those with at least one elevated marker of inflammation but not on mechanical ventilation.
More news on: Eli Lilly and Company, Incyte Corporation, Healthcare stocks news,